Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Godkin

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|December 15, 2006
T-cell costimulationMatt P Wise, Awen Gallimore, Andrew Godkin
Frontiers in Immunology|July 13, 2013
Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not EnoughChristopher J Holland, David K Cole, Andrew Godkin
Hepatology (Baltimore, Md.)|May 26, 2005
Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsivenessAndrew Godkin, Miles Davenport, Adrian V S Hill
Frontiers in Immunology|July 23, 2013
Home sweet home: the tumor microenvironment as a haven for regulatory T cellsBeatrice Ondondo, Emma Jones, Andrew Godkin, et al.
Immunology|December 4, 2012
Rapid innate control of antigen abrogates adaptive immunityThomas P I Pembroke, Awen M Gallimore, Andrew Godkin
Nature Clinical Practice. Gastroenterology & Hepatology|September 5, 2007
A case of persistent anemia and alcohol abuseGemma Lewis, Matthew P Wise, Christopher Poynton, et al.
Journal of Medical Virology|September 28, 2010
Clinical characteristics of hepatitis E in a "Non-Endemic" populationJeff Turner, Andrew Godkin, Peter Neville, et al.
Trends in Cancer|November 2, 2020
The Dual Role of High Endothelial Venules in Cancer Progression versus ImmunityStefan Milutinovic, Jun Abe, Andrew Godkin, et al.
Gastro Hep Advances|January 29, 2025
Regulatory T Cells Play a Role in Determining the Tumourigenicity of the Intestinal Stem Cell NicheAna Padilha, Emma Jones, Scott Cutting, et al.
Immunology|February 21, 2018
T-cell modulation by cyclophosphamide for tumour therapyEllyn Hughes, Martin Scurr, Emma Campbell, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|December 15, 2006
T-cell costimulationMatt P Wise, Awen Gallimore, Andrew Godkin
Frontiers in Immunology|July 13, 2013
Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not EnoughChristopher J Holland, David K Cole, Andrew Godkin
Hepatology (Baltimore, Md.)|May 26, 2005
Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsivenessAndrew Godkin, Miles Davenport, Adrian V S Hill
Frontiers in Immunology|July 23, 2013
Home sweet home: the tumor microenvironment as a haven for regulatory T cellsBeatrice Ondondo, Emma Jones, Andrew Godkin, et al.
Immunology|December 4, 2012
Rapid innate control of antigen abrogates adaptive immunityThomas P I Pembroke, Awen M Gallimore, Andrew Godkin
Nature Clinical Practice. Gastroenterology & Hepatology|September 5, 2007
A case of persistent anemia and alcohol abuseGemma Lewis, Matthew P Wise, Christopher Poynton, et al.
Journal of Medical Virology|September 28, 2010
Clinical characteristics of hepatitis E in a "Non-Endemic" populationJeff Turner, Andrew Godkin, Peter Neville, et al.
Trends in Cancer|November 2, 2020
The Dual Role of High Endothelial Venules in Cancer Progression versus ImmunityStefan Milutinovic, Jun Abe, Andrew Godkin, et al.
Gastro Hep Advances|January 29, 2025
Regulatory T Cells Play a Role in Determining the Tumourigenicity of the Intestinal Stem Cell NicheAna Padilha, Emma Jones, Scott Cutting, et al.
Immunology|February 21, 2018
T-cell modulation by cyclophosphamide for tumour therapyEllyn Hughes, Martin Scurr, Emma Campbell, et al.
Pageof 7